Biogen And Stoke Therapeutics Announce First Patient Dosed In Phase 3 Emperor Study Of Zorevunersen
ReutersAug 11, 2025 11:11 AM
Aug 11 (Reuters) - Biogen Inc BIIB.O:
BIOGEN AND STOKE THERAPEUTICS ANNOUNCE FIRST PATIENT DOSED IN PHASE 3 EMPEROR STUDY OF ZOREVUNERSEN, A POTENTIAL DISEASE-MODIFYING TREATMENT FOR DRAVET SYNDROME
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Seth Klarman Portfolio
TradingKey - Seth Klarman, the Baupost value investor, long had the distinction of navigating doubt with surgeon-like precision. The technique is married to asymmetric bets, deep margin-of-safety work, and, of course, in many cases, a dash of contrarian genius.TradingKey
13 minutes ago
.jfif)
U.S. Stock Strategy: The Rapid Development of AI Signals a Promising Future
TradingKey - Since Trump announced a 90-day suspension of the "reciprocal tariffs" imposed on certain countries on 9 April this year, all three major U.S. stock indices have recorded significant gains. Looking ahead, against the backdrop of easing global trade frictions.TradingKey
15 hours ago
China July Inflation Commentary: CPI Exceeds Expectations
TradingKey - On 9 August 2025, China's National Bureau of Statistics released inflation data for July. The Consumer Price Index (CPI) rose by 0.4% month-on-month, reversing the previous month's 0.1% decline, while remaining unchanged year-on-year. Core CPI increased by 0.8% year-on-year.TradingKey
Mon, Aug 11
U.S. CPI Preview: Bullish Outlook for U.S. Stocks Continues
TradingKey - On 12 August 2025, the U.S. will release its July CPI data. Market consensus forecasts a year-over-year headline CPI increase of 2.8% and a core CPI rise of 3%, both up 0.1 percentage points from June. We align with these widely held market expectations. Breaking it down by category...TradingKey
Mon, Aug 11
[IN-DEPTH ANALYSIS] LULU: Can it Recover from the Drop?
TradingKey - Thesis Among the stocks of the twenty largest clothing companies by revenue, Lululemon has the fifth lowest forward PE ratio. With all the negative sentiment revolving around the stock, we believe their multiple should be higher.TradingKey
Mon, Jun 16
